MedPath

LoSeasonique

These highlights do not include all the information needed to use LoSeasonique tablets safely and effectively. See full prescribing information for LoSeasonique.LoSeasonique (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) for oral useInitial U.S. Approval: 1982

Approved
Approval ID

676f6a52-8d82-4289-ae35-28eb4fbbc184

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 10, 2012

Manufacturers
FDA

Physicians Total Care, Inc.

DUNS: 194123980

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

levonorgestrel/ethinyl estradiol and ethinyl estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code54868-6275
Application NumberNDA022262
Product Classification
M
Marketing Category
C73594
G
Generic Name
levonorgestrel/ethinyl estradiol and ethinyl estradiol
Product Specifications
Effective DateJanuary 10, 2012
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LoSeasonique - FDA Drug Approval Details